Merck & Co

ALEXANDRIA, VA, June 27, 2023 (GLOBE NEWSWIRE) -- Global Impact, as fiscal sponsor for the Advancing Health Online (AHO) Initiative, is pleased to announce the selection of 11 organizations that will receive grants totaling $5 million…

ROME, June 22, 2023 (GLOBE NEWSWIRE) -- IRBM, an innovative contract research organization, today announced it has signed a new agreement with Merck & Co. Inc., Rahway NJ USA, known as MSD outside the USA and Canada, to continue…

Alexandria, VA, Aug. 05, 2022 (GLOBE NEWSWIRE) -- Global Impact, on behalf of the Alliance for Advancing Health Online (AAHO), is pleased to announce the launch of an additional round of Request for Proposals (RFP) for the Vaccine…

Alexandria, VA, May 25, 2022 (GLOBE NEWSWIRE) -- Today, a preliminary insights report from research supported through the Vaccine Confidence Fund was released at the 75th World Health Assembly. The global research is intended to reveal…

By Associated Press WASHINGTON: Merck & Co. said Friday that its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus and that it would soon ask…

Hetero Labs, a Hyderabad-based pharmaceutical company, said on Friday that it has sought an emergency use nod from the local regulator for coronavirus disease (Covid-19) drug Molnupiravir, after interim data from a late-stage trial showed…

MSD has signed agreements with Cipla Ltd., Dr. Reddy’s Laboratories, Emcure Pharmaceuticals Ltd., Hetero Labs Ltd. and Sun Pharmaceutical Industries Ltd MSD Pharmaceuticals Pvt. Ltd., a wholly-owned subsidiary of Merck Sharp &…